Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System

Background: A variety of prescriptions and over-the-counter medications interfere with transcutaneous continuous glucose monitoring (CGM) sensors. This study characterized the interference profile of the Eversense(®) CGM System (Senseonics, Inc., Germantown, MD), which has a different mechanism of g...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenz, Carrie, Sandoval, Wendolyn, Mortellaro, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963543/
https://www.ncbi.nlm.nih.gov/pubmed/29600877
http://dx.doi.org/10.1089/dia.2018.0028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963543/
https://www.ncbi.nlm.nih.gov/pubmed/29600877
http://dx.doi.org/10.1089/dia.2018.0028

Ejemplares similares